Telo Genomics Corp. (TSXV:TELO)

Canada flag Canada · Delayed Price · Currency is CAD
0.0900
-0.0050 (-5.26%)
Apr 24, 2025, 3:38 PM EDT
-47.06%
Market Cap 9.00M
Revenue (ttm) n/a
Net Income (ttm) -2.37M
Shares Out 100.02M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 23,000
Average Volume 24,200
Open 0.0850
Previous Close 0.0950
Day's Range 0.0850 - 0.0900
52-Week Range 0.0800 - 0.2300
Beta 0.39
RSI 39.10
Earnings Date May 16, 2025

About Telo Genomics

Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions primarily in Canada. Its TeloView platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive of genomic instability to identify specific disease mechanisms, predict disease risks, and determine effective treatments. Its lead product is TeloView-SMM (Smolde... [Read more]

Sector Healthcare
CEO Sabine Mai
Employees 6
Stock Exchange TSX Venture Exchange
Ticker Symbol TELO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.